188 related articles for article (PubMed ID: 31481299)
1. Bladder cancer survival: Women only fare worse in the first two years after diagnosis.
Richters A; Dickman PW; Witjes JA; Boormans JL; Kiemeney LALM; Aben KKH
Urol Oncol; 2019 Dec; 37(12):853-861. PubMed ID: 31481299
[TBL] [Abstract][Full Text] [Related]
2. Sex Differences in Urothelial Bladder Cancer Survival.
Radkiewicz C; Edgren G; Johansson ALV; Jahnson S; Häggström C; Akre O; Lambe M; Dickman PW
Clin Genitourin Cancer; 2020 Feb; 18(1):26-34.e6. PubMed ID: 31787542
[TBL] [Abstract][Full Text] [Related]
3. Bladder cancer survival: Women better off in the long run.
Andreassen BK; Grimsrud TK; Haug ES
Eur J Cancer; 2018 May; 95():52-58. PubMed ID: 29635144
[TBL] [Abstract][Full Text] [Related]
4. Impact of sex difference on survival of bladder cancer: A population-based registry data in Japan.
Nakayama M; Ito Y; Hatano K; Nakai Y; Kakimoto KI; Miyashiro I; Nishimura K
Int J Urol; 2019 Jun; 26(6):649-654. PubMed ID: 30916420
[TBL] [Abstract][Full Text] [Related]
5. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
6. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume.
Goossens-Laan CA; Visser O; Hulshof MC; Wouters MW; Bosch JL; Coebergh JW; Kil PJ
BJU Int; 2012 Jul; 110(2):226-32. PubMed ID: 22044615
[TBL] [Abstract][Full Text] [Related]
7. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
9. Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy.
Krimphove MJ; Szymaniak J; Marchese M; Tully KH; D'Andrea D; Mossanen M; Lipsitz SR; Kilbridge K; Kibel AS; Kluth LA; Shariat SF; Trinh QD
Eur Urol Focus; 2021 Jan; 7(1):124-131. PubMed ID: 31227463
[TBL] [Abstract][Full Text] [Related]
10. High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
Burgess EF; Livasy C; Trufan S; Hartman A; Guerreri R; Naso C; Clark PE; Grigg C; Symanowski J; Raghavan D
Urol Oncol; 2019 Dec; 37(12):900-906. PubMed ID: 31597600
[TBL] [Abstract][Full Text] [Related]
11. Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca Cancer Registry associated to survival.
Ripoll J; Ramos M; Montaño J; Pons J; Ameijide A; Franch P
BMC Cancer; 2021 Jun; 21(1):676. PubMed ID: 34098901
[TBL] [Abstract][Full Text] [Related]
12. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S
Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529
[TBL] [Abstract][Full Text] [Related]
13. Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study.
Tracey E; Watt H; Currow D; Young J; Armstrong B
BJU Int; 2014 Mar; 113(3):437-48. PubMed ID: 24127730
[TBL] [Abstract][Full Text] [Related]
14. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG
Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893
[TBL] [Abstract][Full Text] [Related]
15. Long-term trends in sex difference in bladder cancer survival 1975-2009: A population-based study in Osaka, Japan.
Aoe J; Ito Y; Fukui K; Nakayama M; Morishima T; Miyashiro I; Sobue T; Nakayama T
Cancer Med; 2020 Oct; 9(19):7330-7340. PubMed ID: 32794368
[TBL] [Abstract][Full Text] [Related]
16. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
17. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
18. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
Welty CJ; Sanford TH; Wright JL; Carroll PR; Cooperberg MR; Meng MV; Porten SP
Cancer; 2017 Dec; 123(23):4574-4582. PubMed ID: 28881475
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
[TBL] [Abstract][Full Text] [Related]
20. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
